These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28511286)

  • 1. Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials.
    Witkiewitz K; Pearson MR; Hallgren KA; Maisto SA; Roos CR; Kirouac M; Wilson AD; Montes KS; Heather N
    Addiction; 2017 Dec; 112(12):2112-2121. PubMed ID: 28511286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial.
    Witkiewitz K; Vowles KE; McCallion E; Frohe T; Kirouac M; Maisto SA
    Addiction; 2015 Aug; 110(8):1262-71. PubMed ID: 25919978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom.
    Witkiewitz K; Heather N; Falk DE; Litten RZ; Hasin DS; Kranzler HR; Mann KF; O'Malley SS; Anton RF
    Addiction; 2020 Sep; 115(9):1668-1680. PubMed ID: 32056311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Alcohol; 2012 Mar; 46(2):121-31. PubMed ID: 21925828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.
    Witkiewitz K; Bowen S; Donovan DM
    J Consult Clin Psychol; 2011 Feb; 79(1):54-63. PubMed ID: 21261434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.
    Subbaraman MS; Metrik J; Patterson D; Swift R
    Addiction; 2017 Apr; 112(4):685-694. PubMed ID: 27865015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT.
    Gueorguieva R; Wu R; O'Connor PG; Weisner C; Fucito LM; Hoffmann S; Mann K; O'Malley SS
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2647-2656. PubMed ID: 25346505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
    Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
    Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between medication adherence and treatment outcomes: the COMBINE study.
    Zweben A; Pettinati HM; Weiss RD; Youngblood M; Cox CE; Mattson ME; Gorroochurn P; Ciraulo D
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1661-9. PubMed ID: 18616687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of drinking goal on treatment outcome for alcoholism.
    Bujarski S; O'Malley SS; Lunny K; Ray LA
    J Consult Clin Psychol; 2013 Feb; 81(1):13-22. PubMed ID: 23231573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.
    Gueorguieva R; Wu R; Krystal JH; Donovan D; O'Malley SS
    Addict Behav; 2013 May; 38(5):2119-27. PubMed ID: 23435273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Drug Alcohol Depend; 2010 Mar; 107(2-3):221-9. PubMed ID: 19969427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding success in failure: using latent profile analysis to examine heterogeneity in psychosocial functioning among heavy drinkers following treatment.
    Wilson AD; Bravo AJ; Pearson MR; Witkiewitz K
    Addiction; 2016 Dec; 111(12):2145-2154. PubMed ID: 27367263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.